Title :

Efficacy and Safety of Adalimumab After lnfliximab Failure in Pediatric Crohn Disease

Author(s) :

Fumery, Mathurin [Auteur]
Jacob, Anne [Auteur]
Sarter, Helene [Auteur]
Michaud, Laurent [Auteur]
Lille Inflammation Research International Center - U 995 [LIRIC]
Lille Inflammation Research International Center - U 995 [LIRIC]
Spyckerelle, Claire [Auteur]
Mouterde, Olivier [Auteur]
Savoye, Guillaume [Auteur]
Colombel, Jean-Frederic [Auteur]
Peyrin-Biroulet, Laurent [Auteur]
Gower, Corinne [Auteur]
Lille Inflammation Research International Center - U 995 [LIRIC]
Lille Inflammation Research International Center - U 995 [LIRIC]
Turck, Dominique [Auteur]
Lille Inflammation Research International Center - U 995 [LIRIC]
Lille Inflammation Research International Center - U 995 [LIRIC]

Journal title :

Journal of pediatric gastroenterology and nutrition

Abbreviated title :

J. Pediatr. Gastroenterol. Nutr.

Volume number :

60

Pages :

744-748

Publication date :

2015-06-01

ISSN :

0277-2116

Keyword(s) :

growth
pediatric-onset Crohn disease
population-based study
adalimumab

HAL domain(s) :

Sciences du Vivant [q-bio]

Language :

Anglais

Audience :

Internationale

Popular science :

Non

Administrative institution(s) :

Inserm
Université de Lille
CHU Lille

Collections :

• Institut de Recherche Translationnelle sur l'Inflammation (INFINITE) - U1286

Research team(s) :

Inflammatory digestive disease : pathophysiology and therapeutic targets developement
Nutritional modulation of inflammation and infection
IBD and environnemental factors : epidemiology and functional analyses

Submission date :

2019-03-01T14:58:54Z